Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.9%

1 terminated/withdrawn out of 53 trials

Success Rate

94.1%

+7.5% vs industry average

Late-Stage Pipeline

17%

9 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

12 recruiting

Enrollment Performance

Analytics

N/A
21(58.3%)
Phase 2
6(16.7%)
Phase 4
5(13.9%)
Phase 3
4(11.1%)
36Total
N/A(21)
Phase 2(6)
Phase 4(5)
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (53)

Showing 20 of 53 trials
NCT07854665Not ApplicableNot Yet Recruiting

A Randomized Controlled Clinical Trial of Transcutaneous Auricular Point Electrical Stimulation for Improving Symptoms of Chronic Tic Disorders in Children/Adolescents

Role: collaborator

NCT07759323Not ApplicableNot Yet Recruiting

Polygonatum Sibiricum Reduces Visceral Fat in Obese Adults

Role: lead

NCT06760052Recruiting

Longitudinal Data Registry of Plasma Cell Dyscrasia

Role: collaborator

NCT07718503Not ApplicableNot Yet Recruiting

A Study on the Combination of Tongluo Huayu Formula in Treating RVO of Phlegm-Stasis Intertwinement Type: Based on the Mechanism of Systemic Metabolic Regulation Mediated by Gut Microbiota

Role: collaborator

NCT07690410Not Yet Recruiting

TMP-SMX for Non-HIV PCP: A Prospective Multicenter Study

Role: collaborator

NCT04793672Completed

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Role: collaborator

NCT07669194Not Yet Recruiting

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Role: collaborator

NCT07654348Phase 2Not Yet Recruiting

Efficacy and Mechanism of IPSRT for Bipolar II Disorder

Role: collaborator

NCT07638449Not ApplicableNot Yet Recruiting

Silkworm Pupa Powder Improves Alzheimer's Disease

Role: lead

NCT06898476Not ApplicableRecruiting

Silkworm Pupa Powder Improves Dementia.

Role: lead

NCT07616518Not Yet Recruiting

Dynamic Trajectories of Pupillary Light Reflex Parameters and Prognosis in Critically Ill Patients: A Multicenter Prospective Cohort Study

Role: collaborator

NCT07554898Phase 2Recruiting

Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma

Role: collaborator

NCT07548073Not ApplicableCompleted

Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease

Role: lead

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT03785574Not ApplicableRecruiting

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Role: collaborator

NCT07413809Phase 3Recruiting

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Role: collaborator

NCT06164561Recruiting

18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT06520163Phase 3Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Role: collaborator

NCT05524519Not ApplicableCompleted

Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder

Role: collaborator